Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Receivables (2020 - 2025)

Historic Receivables for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $37.5 million.

  • Strata Critical Medical's Receivables rose 5333.52% to $37.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 5333.52%. This contributed to the annual value of $19.8 million for FY2024, which is 563.2% down from last year.
  • Per Strata Critical Medical's latest filing, its Receivables stood at $37.5 million for Q3 2025, which was up 5333.52% from $28.2 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Receivables peaked at $37.5 million during Q3 2025, and registered a low of $1.7 million during Q2 2021.
  • Over the past 5 years, Strata Critical Medical's median Receivables value was $20.4 million (recorded in 2023), while the average stood at $17.4 million.
  • In the last 5 years, Strata Critical Medical's Receivables surged by 46495.33% in 2022 and then crashed by 603.82% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Receivables stood at $5.5 million in 2021, then skyrocketed by 96.05% to $10.9 million in 2022, then soared by 93.11% to $21.0 million in 2023, then fell by 5.63% to $19.8 million in 2024, then skyrocketed by 89.38% to $37.5 million in 2025.
  • Its last three reported values are $37.5 million in Q3 2025, $28.2 million for Q2 2025, and $22.1 million during Q1 2025.